recurrent basal cell carcinoma
Showing 1 - 1 of 1
Recurrent Basal Cell Carcinoma Trial in United States (Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle)
Terminated
- Recurrent Basal Cell Carcinoma
- Patidegib Topical Gel, 2%
- Patidegib Topical Gel, Vehicle
-
Apple Valley, California
- +13 more
May 25, 2021